Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: AHM who wrote (744)	7/2/1998 12:12:00 PM
From: Jonas Grumby	Respond to of 1510

AHM (spitooey)...little cheese with your whine? (eom)

To: AHM who wrote (744)	7/2/1998 12:14:00 PM
From: Sly_	Respond to of 1510

Yoooo, AHM, ya need a violin there :} (E)

To: AHM who wrote (744)	7/2/1998 12:18:00 PM
From: Brian Thomas Hertzog	Read Replies (1) \| Respond to of 1510

AHM, What market makers do and where they stand on a stock is very, very important. Institutional traders and investment bankers work sales from both the buy and sell side according to their customers desires. Let's say If an institution, one of OPCO's customers, wants to sell a block trade OPCO will try to find someone else on the other side to buy the block. Hence, they receive commission on both sides (crossing stock). If they are a market maker for a company, IMNR, they want to be the firm that people come to if they want to trade IMNR. They also want to show the company, IMNR, that they are moving the most shares. Hence, if IMNR wants to do a public offering or any other form of investment banking; Who will they turn to? Oppenheimer